Adherence Patterns to Prenatal Vitamins and Pregnancy Health Behaviours
Publisher
Springer Singapore
Reference40 articles.
1. A.A.P. (1999). Folic acid for the prevention of neural tube defects. American Academy of Pediatrics. Committee on Genetics. Pediatrics, 104, 325–327. 2. Anderson, J. E., Ebrahim, S., Floyd, L., & Atrash, H. (2006). Prevalence of risk factors for adverse pregnancy outcomes during pregnancy and the preconception period—United States, 2002–2004. Maternal and Child Health Journal, 10, 101–106. 3. Asad, N., Karmaliani, R., Sullaiman, N., Bann, C. M., McClure, E. M., Pasha, O., Wright, L. L., & Goldenberg, R. L. (2010). Prevalence of suicidal thoughts and attempts among pregnant Pakistani women. Acta Obstetricia Et Gynecologica Scandinavica, 89, 1545–1551. 4. Bardeguez, A. D., Lindsey, J. C., Shannon, M., Tuomala, R. E., Cohn, S. E., Smith, E., Stek, A., Buschur, S., Cotter, A., Bettica, L., Read, J. S., & Team, P. P. (2008). Adherence to antiretrovirals among US women during and after pregnancy. Journal of Acquired Immune Deficiency Syndromes, 48, 408–417. 5. CDC. (1992). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morbidity and mortality weekly report. Recommendations and Reports, 41, 1–7.
|
|